Risk factors and biomarkers of age-related macular degeneration
暂无分享,去创建一个
Ruth E. Hogg | Balamurali K. Ambati | D. Keegan | R. Hogg | F. Mansergh | Malkit Singh | M. Wride | B. Ambati | Nathan G. Lambert | Hanan Elshelmani | Maximilian Padilla | David Keegan | Hanan ElShelmani | Malkit K. Singh | Fiona C. Mansergh | Michael A. Wride | Maximilian Padilla
[1] R. Pruett,et al. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy , 1994, Nature Genetics.
[2] M. Saha,et al. A study on plasma homocysteine level in age-related macular degeneration. , 2013, Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH.
[3] J. J. Wang,et al. Iris color, skin sun sensitivity, and age-related maculopathy. The Blue Mountains Eye Study. , 1998, Ophthalmology.
[4] R. Klein,et al. Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. , 1993, Archives of ophthalmology.
[5] B. Gold,et al. Multilocus analysis of age-related macular degeneration , 2009, European Journal of Human Genetics.
[6] P. Mitchell,et al. Smoking and age-related macular degeneration: a review of association , 2005, Eye.
[7] M. Pepe,et al. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. , 2004, American journal of epidemiology.
[8] T. Wong,et al. Association of genetic variants on 8p21 and 4q12 with age-related macular degeneration in Asian populations. , 2012, Investigative ophthalmology & visual science.
[9] D. Clayton,et al. Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation , 2005, British Journal of Ophthalmology.
[10] A. Bird,et al. Age-related macular disease. , 1996, The British journal of ophthalmology.
[11] E. Stone,et al. The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice. , 2007, Human molecular genetics.
[12] J. Grunwald,et al. Changes in Choriocapillaris and Retinal Pigment Epithelium ( RPE ) in Age-Related Macular Degeneration , 1999 .
[13] M. Yaseri,et al. Investigating the CFH Gene Polymorphisms as a Risk Factor for Age-related Macular Degeneration in an Iranian Population , 2016, Ophthalmic genetics.
[14] M. Brantley,et al. The effect of genetic variants in SERPING1 on the risk of neovascular age-related macular degeneration , 2010, British Journal of Ophthalmology.
[15] R. T. Smith,et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[16] G. Jensen,et al. Risk factors for age-related maculopathy in a 14-year follow-up study: the Copenhagen City Eye Study. , 2005, Acta ophthalmologica Scandinavica.
[17] R. Khokha,et al. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. , 1994, The Journal of biological chemistry.
[18] R. Glynn,et al. Body mass index and the incidence of visually significant age-related maculopathy in men. , 2001, Archives of ophthalmology.
[19] A. D. den Hollander,et al. Clinical and genetic characteristics of late-onset Stargardt's disease. , 2012, Ophthalmology.
[20] B. Rosner,et al. Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration. , 2010, Ophthalmology.
[21] Xueshan Xiao,et al. The 208delG mutation in FSCN2 does not associate with retinal degeneration in Chinese individuals. , 2007, Investigative ophthalmology & visual science.
[22] R. T. Smith,et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.
[23] M. Gillies,et al. Immunological and Aetiological Aspects of Macular Degeneration , 2001, Progress in Retinal and Eye Research.
[24] M. Stoffel,et al. MicroRNAs: a new class of regulatory genes affecting metabolism. , 2006, Cell metabolism.
[25] R. Klein,et al. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.
[26] D. Friedman,et al. Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. , 1999, Ophthalmology.
[27] P. Chinnery,et al. Mitochondrial optic neuropathies – Disease mechanisms and therapeutic strategies , 2011, Progress in Retinal and Eye Research.
[28] I. Chowers,et al. Retinal Phenotype following Combined Deletion of the Chemokine Receptor CCR2 and the Chemokine CX3CL1 in Mice , 2015, Ophthalmic Research.
[29] Johanna M Seddon,et al. Variation in complement factor 3 is associated with risk of age-related macular degeneration , 2007, Nature Genetics.
[30] J. Hollyfield,et al. A Hapten Generated from an Oxidation Fragment of Docosahexaenoic Acid Is Sufficient to Initiate Age-Related Macular Degeneration , 2010, Molecular Neurobiology.
[31] John D Lambris,et al. Drusen complement components C3a and C5a promote choroidal neovascularization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[32] M. Jovanović,et al. miRNAs and apoptosis: RNAs to die for , 2006, Oncogene.
[33] V. Sheffield,et al. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy , 1999, Nature Genetics.
[34] J. Hejtmancik,et al. Homozygous null mutations in the ABCA4 gene in two families with autosomal recessive retinal dystrophy. , 2006, American journal of ophthalmology.
[35] K. Gumus,et al. Plasma homocysteine, vitamin B12 and folate levels in age-related macular degeneration , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.
[36] S. Teper,et al. Involvement of genetic factors in the response to a variable-dosing ranibizumab treatment regimen for age-related macular degeneration , 2010, Molecular vision.
[37] E. Chew,et al. Genetic studies of age-related macular degeneration: lessons, challenges, and opportunities for disease management. , 2012, Ophthalmology.
[38] D. English,et al. Abdominal obesity and age-related macular degeneration. , 2011, American journal of epidemiology.
[39] Wei Shen,et al. Altered MicroRNA Expression Profiles in Retinas with Diabetic Retinopathy , 2011, Ophthalmic Research.
[40] P. Mitchell,et al. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. , 2008, Ophthalmology.
[41] G. Hannon,et al. Control of translation and mRNA degradation by miRNAs and siRNAs. , 2006, Genes & development.
[42] N. Clarke,et al. Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review. , 2009, Health technology assessment.
[43] S. Fisher,et al. Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA , 2008, Nature Genetics.
[44] I. Mantel,et al. Complement Factor B Polymorphism and the Phenotype of Early Age-related Macular Degeneration , 2014, Ophthalmic genetics.
[45] M. Klein,et al. Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. , 2003, Human molecular genetics.
[46] G. Petrovski,et al. Molecular mechanisms of retinal pigment epithelium damage and development of age‐related macular degeneration , 2012, Acta ophthalmologica.
[47] Aaron Y. Lee,et al. Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration , 2009, Molecular vision.
[48] R. Simó,et al. Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor. , 2010, Investigative ophthalmology & visual science.
[49] K. Lashkari,et al. Interferon gamma-inducible protein-10 (IP-10) and eotaxin as biomarkers in age-related macular degeneration. , 2010, Investigative ophthalmology & visual science.
[50] S. Russell,et al. Clinically detectable drusen domains in fibulin-5-associated age-related macular degeneration (AMD) , 2016, International Ophthalmology.
[51] M. Belkin,et al. The association between cigarette smoking and ocular diseases. , 1998, Survey of ophthalmology.
[52] Stefanie Dimmeler,et al. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. , 2008, Cardiovascular research.
[53] J. Sahel,et al. APOE Isoforms Control Pathogenic Subretinal Inflammation in Age-Related Macular Degeneration , 2015, The Journal of Neuroscience.
[54] Eiji Sakurai,et al. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice , 2003, Nature Medicine.
[55] Matthew D. Davis,et al. The Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration , 2015 .
[56] N. Yan,et al. Profiling microRNAs differentially expressed in rabbit retina. , 2010, Advances in experimental medicine and biology.
[57] J. Sinsheimer,et al. Association of Sequence Variation in the CX3CR1 Gene with Geographic Atrophy Age-related Macular Degeneration in a Greek Population , 2012, Current eye research.
[58] D. Scherman,et al. CD36 Deficiency Leads to Choroidal Involution via COX2 Down-Regulation in Rodents , 2008, PLoS medicine.
[59] M. Radic,et al. Autoimmune biomarkers in age-related macular degeneration: a possible role player in disease development and progression. , 2012, Advances in experimental medicine and biology.
[60] T. Wong,et al. MMP20 and ARMS2/HTRA1 Are Associated with Neovascular Lesion Size in Age-Related Macular Degeneration. , 2015, Ophthalmology.
[61] M. McKibbin,et al. CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration , 2011, British Journal of Ophthalmology.
[62] S. Ennis,et al. Determination of a gene and environment risk model for age-related macular degeneration , 2010, British Journal of Ophthalmology.
[63] Jinqiao Qian,et al. Effect of miR-23 on oxidant-induced injury in human retinal pigment epithelial cells. , 2011, Investigative ophthalmology & visual science.
[64] F. Wen,et al. Different impact of high-density lipoprotein-related genetic variants on polypoidal choroidal vasculopathy and neovascular age-related macular degeneration in a Chinese Han population. , 2013, Experimental eye research.
[65] J. Haines,et al. Localization of age-related macular degeneration-associated ARMS2 in cytosol, not mitochondria. , 2009, Investigative ophthalmology & visual science.
[66] W. Hauswirth,et al. ERK1/2 activation is a therapeutic target in age-related macular degeneration , 2012, Proceedings of the National Academy of Sciences.
[67] M. Tamai,et al. Autosomal dominant macular degeneration associated with 208delG mutation in the FSCN2 gene. , 2003, Archives of ophthalmology.
[68] Y. Nose,et al. The 5-year incidence and risk factors for age-related maculopathy in a general Japanese population: the Hisayama study. , 2005, Investigative ophthalmology & visual science.
[69] M. C. Leske,et al. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. , 2000, Archives of ophthalmology.
[70] L. McCarthy,et al. Pharmacogenetic associations with long-term response to anti-vascular endothelial growth factor treatment in neovascular AMD patients , 2014, Molecular vision.
[71] Yang Wang,et al. Genome-wide association identifies SKIV2L and MYRIP as protective factors for age-related macular degeneration , 2010, Genes and Immunity.
[72] E. Pugh,et al. Altered visual function in monocarboxylate transporter 3 (Slc16a8) knockout mice. , 2008, American Journal of Physiology - Cell Physiology.
[73] Brian C. Stagg,et al. The reduction of serum soluble Flt-1 in patients with neovascular age-related macular degeneration. , 2015, American journal of ophthalmology.
[74] P. Hardy,et al. CD36 plays an important role in the clearance of oxLDL and associated age-dependent sub-retinal deposits , 2010, Aging.
[75] Liangqi Xie,et al. C-Reactive Protein Augments Interleukin-8 Secretion in Human Peripheral Blood Monocytes , 2005, Journal of cardiovascular pharmacology.
[76] Cheolju Lee,et al. Comparative analysis of aqueous humor cytokine levels between patients with exudative age-related macular degeneration and normal controls. , 2013, Investigative ophthalmology & visual science.
[77] E. Stone,et al. Localization of complement 1 inhibitor (C1INH/SERPING1) in human eyes with age-related macular degeneration. , 2009, Experimental eye research.
[78] A. Pinna,et al. Plasma Homocysteine and Asymmetrical Dimethyl-l-Arginine (ADMA) and Whole Blood DNA Methylation in Early and Neovascular Age-Related Macular Degeneration: A Pilot Study* , 2016, Current eye research.
[79] E. Świętochowska,et al. Homocysteine, vitamin B12, and folic acid in age-related macular degeneration. , 2005, European journal of ophthalmology.
[80] P. D. de Jong,et al. Sunlight exposure, antioxidants, and age-related macular degeneration. , 2008, Archives of ophthalmology.
[81] H. Petty,et al. MCP-1-activated monocytes induce apoptosis in human retinal pigment epithelium. , 2011, Investigative ophthalmology & visual science.
[82] J S Sunness,et al. Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration. , 1999, Ophthalmology.
[83] C. McCarty,et al. Iris colour, ethnic origin and progression of age‐related macular degeneration , 2003, Clinical & experimental ophthalmology.
[84] J. Haines,et al. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. , 2007, Human molecular genetics.
[85] R. Frank,et al. Race, iris color, and age-related macular degeneration. , 2000, Transactions of the American Ophthalmological Society.
[86] K. Fukuda,et al. Dynamic changes of microRNAs in the eye during the development of experimental autoimmune uveoretinitis. , 2011, Investigative ophthalmology & visual science.
[87] C. Croce,et al. miRNAs, Cancer, and Stem Cell Division , 2005, Cell.
[88] R. Gregory,et al. Many roads to maturity: microRNA biogenesis pathways and their regulation , 2009, Nature Cell Biology.
[89] Hans-Peter Lenhof,et al. Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy Controls , 2009, PloS one.
[90] R. Guymer,et al. POLYMORPHISMS IN THE APOE GENE AND THE LOCATION OF RETINAL FLUID IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2014, Retina.
[91] R. Molday,et al. N-Retinylidene-phosphatidylethanolamine Is the Preferred Retinoid Substrate for the Photoreceptor-specific ABC Transporter ABCA4 (ABCR)* , 2004, Journal of Biological Chemistry.
[92] P. Campochiaro,et al. Periocular gene transfer of sFlt-1 suppresses ocular neovascularization and vascular endothelial growth factor-induced breakdown of the blood-retinal barrier. , 2003, Human gene therapy.
[93] P. Mitchell,et al. Smoking and age-related maculopathy. The Blue Mountains Eye Study. , 1996, Archives of ophthalmology.
[94] Neel Kamal Sharma,et al. Single Nucleotide Polymorphisms in MCP-1 and Its Receptor Are Associated with the Risk of Age Related Macular Degeneration , 2012, PloS one.
[95] R. Klein,et al. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. , 2003, Ophthalmology.
[96] Robert F. Mullins,et al. An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration , 2001, Progress in Retinal and Eye Research.
[97] Margaret A. Pericak-Vance,et al. Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration , 2010, Proceedings of the National Academy of Sciences.
[98] P. Onkamo,et al. The genetic variant rs4073 A→T of the Interleukin‐8 promoter region is associated with the earlier onset of exudative age‐related macular degeneration , 2015, Acta ophthalmologica.
[99] E. Ng,et al. Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. , 2005, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[100] J. Seddon,et al. Genetic epidemiology: successes and challenges of genome-wide association studies using the example of age-related macular degeneration. , 2010, American journal of ophthalmology.
[101] P. Monk,et al. Complement component 5a (C5a). , 2009, The international journal of biochemistry & cell biology.
[102] Chelsea E. Myers,et al. Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degeneration: the Beaver Dam Eye Study. , 2013, JAMA ophthalmology.
[103] Jeremy MG Taylor,et al. Validation of Biomarker-Based Risk Prediction Models , 2008, Clinical Cancer Research.
[104] N. Rifai,et al. Association between C-reactive protein and age-related macular degeneration. , 2004, JAMA.
[105] Xiumei Wang,et al. MicroRNAs couple cell fate and developmental timing in retina , 2009, Proceedings of the National Academy of Sciences.
[106] Baitang Ning,et al. Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[107] Y Zeng,et al. Principles of micro-RNA production and maturation , 2006, Oncogene.
[108] G. Farrar,et al. Mitochondrial disorders: aetiologies, models systems, and candidate therapies. , 2013, Trends in genetics : TIG.
[109] E. Agrón,et al. Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4. , 2013, JAMA ophthalmology.
[110] S. Fisher,et al. Case–control genetic association study of fibulin‐6 (FBLN6 or HMCN1) variants in age‐related macular degeneration (AMD) , 2007, Human mutation.
[111] E. Makalic,et al. Variants in the VEGFA gene and treatment outcome after anti-VEGF treatment for neovascular age-related macular degeneration. , 2013, Ophthalmology.
[112] Klaus Jung,et al. Avoiding pitfalls in applying prediction models, as illustrated by the example of prostate cancer diagnosis. , 2011, Clinical chemistry.
[113] E. Stone. Genetic testing for age-related macular degeneration: not indicated now. , 2015, JAMA ophthalmology.
[114] M. Sampson,et al. Efficacy of ω-3 Fatty Acids in Preventing Age-Related Macular Degeneration : A Systematic Review , 2006 .
[115] M. Goldbaum,et al. Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors. , 2011, Archives of ophthalmology.
[116] Bernd Kirchhof,et al. HISTORY OF SUNLIGHT EXPOSURE IS A RISK FACTOR FOR AGE-RELATED MACULAR DEGENERATION , 2016, Retina.
[117] J. Hollyfield,et al. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components , 2012, Nature Medicine.
[118] C. Ruan,et al. MicroRNA-126 inhibits ischemia-induced retinal neovascularization via regulating angiogenic growth factors. , 2011, Experimental and molecular pathology.
[119] R. Klein,et al. Causes and prevalence of visual impairment among adults in the United States. , 2004, Archives of ophthalmology.
[120] Z. Bian,et al. Induction of interleukin-8 gene expression and protein secretion by C-reactive protein in ARPE-19 cells. , 2010, Experimental eye research.
[121] A. Libunao. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: The blue mountains eye study , 1999 .
[122] E. Kremmer,et al. ARMS2 is a constituent of the extracellular matrix providing a link between familial and sporadic age-related macular degenerations. , 2010, Investigative ophthalmology & visual science.
[123] G. Lip,et al. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. , 2001, Ophthalmology.
[124] P. Jong. Prevalence of age-related macular degeneration in the United States. , 2004 .
[125] E. Agrón,et al. Copy number variations in candidate genes in neovascular age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.
[126] D. Clayton,et al. Age-related macular degeneration: the importance of family history as a risk factor , 2011, British Journal of Ophthalmology.
[127] Jennifer G. Robinson,et al. Genetic evidence for role of carotenoids in age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS). , 2014, Investigative ophthalmology & visual science.
[128] N. Raghavachari,et al. MicroRNA expression in human retinal pigment epithelial (ARPE-19) cells: Increased expression of microRNA-9 by N-(4-Hydroxyphenyl)retinamide , 2010, Molecular vision.
[129] Sarah L. Doyle,et al. An eye on the future of inflammasomes and drug development in AMD , 2013, Journal of Molecular Medicine.
[130] E. Rodriguez-Boulan,et al. The lipofuscin fluorophore A2E perturbs cholesterol metabolism in retinal pigment epithelial cells , 2007, Proceedings of the National Academy of Sciences.
[131] Aaron Y. Lee,et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC) , 2010, Proceedings of the National Academy of Sciences.
[132] E. Olson,et al. Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23∼27∼24 clusters , 2011, Proceedings of the National Academy of Sciences.
[133] E. Agrón,et al. Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration , 2012, Molecular vision.
[134] G. Qiu,et al. CETP Gene may be Associated with Advanced Age-Related Macular Degeneration in the Chinese Population , 2015, Ophthalmic Genetics.
[135] Frederick L Ferris,et al. Age-related macular degeneration , 2008, The Lancet.
[136] M. Taniwaki,et al. DANCE, a Novel Secreted RGD Protein Expressed in Developing, Atherosclerotic, and Balloon-injured Arteries* , 1999, The Journal of Biological Chemistry.
[137] Peiquan Zhao,et al. A genetic variant in the SKIV2L gene is significantly associated with age-related macular degeneration in a Han Chinese population. , 2013, Investigative ophthalmology & visual science.
[138] Mónica García,et al. Cell death in the developing vertebrate retina. , 2004, The International journal of developmental biology.
[139] S. Ennis,et al. Association between the SERPING1 gene and age-related macular degeneration: a two-stage case–control study , 2008, The Lancet.
[140] Aadel A. Chaudhuri,et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder , 2008, The Journal of experimental medicine.
[141] Leonard D. Goldstein,et al. miR-124 acts through CoREST to control onset of Sema3A sensitivity in navigating retinal growth cones , 2011, Nature Neuroscience.
[142] Hua Zhao,et al. A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer , 2010, PloS one.
[143] K. Horie-Inoue,et al. Genomic aspects of age-related macular degeneration. , 2014, Biochemical and biophysical research communications.
[144] J. Raftery,et al. Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness , 2007, British Journal of Ophthalmology.
[145] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[146] Michael T. McManus,et al. MicroRNAs and cancer. , 2003, Seminars in cancer biology.
[147] D. Weeks,et al. C2 and CFB Genes in Age-Related Maculopathy and Joint Action with CFH and LOC387715 Genes , 2008, PloS one.
[148] J. Sears,et al. Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: Implications for age-related macular degeneration , 2006, Proceedings of the National Academy of Sciences.
[149] Lin Wu,et al. Association between polymorphisms of complement pathway genes and age-related macular degeneration in a Chinese population. , 2013, Investigative ophthalmology & visual science.
[150] M. Pangburn,et al. A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration. , 2010, Advances in experimental medicine and biology.
[151] G. Remuzzi,et al. The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome. , 2008, Journal of the American Society of Nephrology : JASN.
[152] François Darchen,et al. MyRIP, a novel Rab effector, enables myosin VIIa recruitment to retinal melanosomes , 2002, EMBO reports.
[153] G. Murthy,et al. Prevalence of early and late age-related macular degeneration in India: the INDEYE study. , 2010, Investigative ophthalmology & visual science.
[154] R. Allikmets,et al. Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. , 2000, American journal of human genetics.
[155] M. Gorin. Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics. , 2012, Molecular aspects of medicine.
[156] Joan W. Miller,et al. Vascular endothelial growth factor a in intraocular vascular disease. , 2013, Ophthalmology.
[157] O. Jacenko,et al. Growth Plate Compressions and Altered Hematopoiesis in Collagen X Null Mice , 2000, The Journal of cell biology.
[158] B. Rosner,et al. C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration. , 2010, Ophthalmology.
[159] P. Mitchell,et al. A review and meta-analysis of the association between C-reactive protein and age-related macular degeneration. , 2011, Survey of ophthalmology.
[160] Roberta McKean-Cowdin,et al. Risk factors for four-year incidence and progression of age-related macular degeneration: the los angeles latino eye study. , 2011, American journal of ophthalmology.
[161] Haiwei Xu,et al. Overexpression of Fibulin-5 in Retinal Pigment Epithelial Cells Inhibits Cell Proliferation and Migration and Downregulates VEGF, CXCR4, and TGFB1 Expression in Cocultured Choroidal Endothelial Cells , 2012, Current eye research.
[162] Dae Hyun Lee,et al. Pharmacogenetic Influence of LOC387715/HTRA1 on the Efficacy of Bevacizumab Treatment for Age-Related Macular Degeneration in a Korean Population , 2012, Korean journal of ophthalmology : KJO.
[163] Nicole A. Restrepo,et al. Genetic determinants of age-related macular degeneration in diverse populations from the PAGE study. , 2014, Investigative ophthalmology & visual science.
[164] Robert W. Williams,et al. Innate immune network in the retina activated by optic nerve crush. , 2013, Investigative ophthalmology & visual science.
[165] Ronald Klein,et al. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. , 2003, Ophthalmology.
[166] Ivana K. Kim,et al. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT). , 2013, Ophthalmology.
[167] M. Brantley,et al. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab. , 2007, Ophthalmology.
[168] A. Fletcher,et al. Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: an add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. , 2004, Ophthalmology.
[169] D. Bourla,et al. Age‐Related Macular Degeneration: A Practical Approach to a Challenging Disease , 2006, Journal of the American Geriatrics Society.
[170] P. Xie,et al. Complement factor H Val62Ile variant and risk of age-related macular degeneration: A meta-analysis , 2013, Molecular vision.
[171] Takeshi Iwata,et al. The association between complement component 2/complement factor B polymorphisms and age-related macular degeneration: a HuGE review and meta-analysis. , 2012, American journal of epidemiology.
[172] G. Omenn,et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.
[173] S. Wijmenga,et al. NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review. , 2012, Analytica chimica acta.
[174] J. Heckenlively,et al. Investigations of antiretinal antibodies in pigmentary retinopathy and other retinal degenerations. , 1996, Transactions of the American Ophthalmological Society.
[175] Usha Chakravarthy,et al. Prevalence of age related maculopathy in northern India , 2004 .
[176] Santa Jeremy Ono,et al. Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization. , 2012, Experimental and molecular pathology.
[177] Glenn J Jaffe,et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. , 2011, The New England journal of medicine.
[178] O. Ates,et al. Evaluation of cardiovascular biomarkers in patients with age-related wet macular degeneration , 2014, Clinical ophthalmology.
[179] J. Castle,et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.
[180] A. Tall,et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. , 1996, The Journal of clinical investigation.
[181] R. Mahley,et al. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.
[182] D. Simpson,et al. Prediction and verification of miRNA expression in human and rat retinas. , 2007, Investigative ophthalmology & visual science.
[183] M. Sampson,et al. Efficacy of omega-3 fatty acids in preventing age-related macular degeneration: a systematic review. , 2006, Ophthalmology.
[184] R. Hogg,et al. Further assessment of the complement component 2 and factor B region associated with age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.
[185] John C Lindon,et al. ¹H NMR-based metabonomics for investigating diabetes. , 2009, Future medicinal chemistry.
[186] R. Kuijpers,et al. Insulin-like growth factor-I and its receptor in neovascular age-related macular degeneration. , 2003, Investigative ophthalmology & visual science.
[187] R. Raman,et al. Plasma homocysteine and total thiol content in patients with exudative age-related macular degeneration , 2006, Eye.
[188] A. Negi,et al. The association of CD36 variants with polypoidal choroidal vasculopathy compared to typical neovascular age-related macular degeneration , 2012, Molecular vision.
[189] G. Abecasis,et al. Genetic testing in persons with age-related macular degeneration and the use of the AREDS supplements: to test or not to test? , 2015, Ophthalmology.
[190] A Hofman,et al. Epidemiology of age-related maculopathy. , 1995, Epidemiologic reviews.
[191] Tayyaba Hasan,et al. Enhanced Susceptibility to Leishmania Infection in Resistant Mice in the Absence of Immediate Early Response Gene X-11 , 2009, The Journal of Immunology.
[192] J. Tong,et al. Functional and structural implications of the complement factor H Y402H polymorphism associated with age-related macular degeneration. , 2008, Investigative ophthalmology & visual science.
[193] Gabriëlle H S Buitendijk,et al. Seven New Loci Associated with Age-Related Macular Degeneration , 2013, Nature Genetics.
[194] R. Klein,et al. Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes. , 2007, Human molecular genetics.
[195] Keda Yu,et al. Association between Variant Y402H in Age-Related Macular Degeneration (AMD) Susceptibility Gene CFH and Treatment Response of AMD: A Meta-Analysis , 2012, PloS one.
[196] A. D. den Hollander,et al. Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration. , 2014, Ophthalmology.
[197] Jian Ge,et al. CFH Y402H Confers Similar Risk of Soft Drusen and Both Forms of Advanced AMD , 2005, PLoS medicine.
[198] A. D. den Hollander,et al. Genetic Variants and Systemic Complement Activation Levels Are Associated With Serum Lipoprotein Levels in Age-Related Macular Degeneration. , 2015, Investigative ophthalmology & visual science.
[199] L. Fernández-Vega,et al. CFH polymorphisms in a Northern Spanish population with neovascular and dry forms of age‐related macular degeneration , 2015, Acta ophthalmologica.
[200] John N. Hutchinson,et al. (Epi)Genetic Analyses of Age-Related Macular Degeneration: Case-Control and Discordant Twin Studies , 2014, Human Heredity.
[201] B. J. Klevering,et al. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration. , 2012, Ophthalmology.
[202] Aaron Y. Lee,et al. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration , 2011, Human molecular genetics.
[203] R. Timpl,et al. Genetic heterogeneity of cutis laxa: a heterozygous tandem duplication within the fibulin-5 (FBLN5) gene. , 2003, American journal of human genetics.
[204] Giovanni Sato,et al. Association of age-related macular degeneration with polymorphisms in vascular endothelial growth factor and its receptor. , 2010, Ophthalmology.
[205] Yadong Wang,et al. miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..
[206] Yuan Tian,et al. Lutein: More than just a filter for blue light , 2012, Progress in Retinal and Eye Research.
[207] Don H. Anderson,et al. Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts , 2006, Annals of medicine.
[208] K. Blennow,et al. Cerebrospinal fluid analysis in Alzheimer’s disease: technical issues and future developments , 2014, Journal of Neurology.
[209] T. Noda,et al. Targeted disruption of FSCN2 gene induces retinopathy in mice. , 2005, Investigative ophthalmology & visual science.
[210] F. Ferris,et al. Age-related macular degeneration and the immune response: implications for therapy. , 2007, American journal of ophthalmology.
[211] P. Mitchell,et al. Lens Status Influences the Association between CFH Polymorphisms and Age-Related Macular Degeneration: Findings from Two Population-Based Studies in Singapore , 2015, PloS one.
[212] Paul Mitchell,et al. Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study. , 2007, Ophthalmology.
[213] Frederick L Ferris,et al. Risk assessment model for development of advanced age-related macular degeneration. , 2011, Archives of ophthalmology.
[214] C. Delcourt,et al. Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liées à l'Age. , 1998, Archives of ophthalmology.
[215] B. Rosner,et al. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. , 2005, Archives of ophthalmology.
[216] M. Bartoli,et al. Vascular endothelial growth factor in eye disease , 2008, Progress in Retinal and Eye Research.
[217] G. Tikellis,et al. Apolipoprotein (APOE) gene is associated with progression of age‐related macular degeneration (AMD) , 2006, Human mutation.
[218] Gary C. Brown,et al. ASSOCIATION BETWEEN HIGH-RISK DISEASE LOCI AND RESPONSE TO ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR WET AGE-RELATED MACULAR DEGENERATION , 2012, Retina.
[219] J. Haines,et al. Dissection of chromosome 16p12 linkage peak suggests a possible role for CACNG3 variants in age-related macular degeneration susceptibility. , 2011, Investigative ophthalmology & visual science.
[220] A. Ivens,et al. Altered retinal microRNA expression profile in a mouse model of retinitis pigmentosa , 2007, Genome Biology.
[221] P. Cignini,et al. Metabolic profile of amniotic fluid as a biochemical tool to screen for inborn errors of metabolism and fetal anomalies , 2011, Molecular and Cellular Biochemistry.
[222] N. Risch,et al. Differences in the Genetic Susceptibility to Age-Related Macular Degeneration Clinical Subtypes. , 2015, Investigative ophthalmology & visual science.
[223] K. Palczewski,et al. Sponge Transgenic Mouse Model Reveals Important Roles for the MicroRNA-183 (miR-183)/96/182 Cluster in Postmitotic Photoreceptors of the Retina* , 2011, The Journal of Biological Chemistry.
[224] N. Hamajima,et al. Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration. , 2007, Ophthalmology.
[225] N. Orr,et al. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration , 2006, Nature Genetics.
[226] Robyn H Guymer,et al. The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. , 2004, Investigative ophthalmology & visual science.
[227] Deeba Husain,et al. Mechanisms of age-related macular degeneration. , 2002, Ophthalmology clinics of North America.
[228] J. Lupski,et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Starqardt macular dystrophy , 1997, Nature Genetics.
[229] M. Morrison,et al. Analysis of Genetic and Environmental Risk Factors and Their Interactions in Korean Patients with Age-Related Macular Degeneration , 2015, PloS one.
[230] M. Byrom,et al. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis , 2005, Nucleic acids research.
[231] R. Goodacre,et al. The role of metabolites and metabolomics in clinically applicable biomarkers of disease , 2010, Archives of Toxicology.
[232] Gonçalo R. Abecasis,et al. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration , 2007, Proceedings of the National Academy of Sciences.
[233] F. Ferris. PROGRESSION OF AGE-RELATED MACULAR DEGENERATION ASSOCIATION WITH DIETARY FAT, TRANSUNSATURATED FAT, NUTS, AND FISH INTAKE , 2004 .
[234] Chi Pui Pang,et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. , 2007, Science.
[235] R. Aharonov,et al. Identification of hundreds of conserved and nonconserved human microRNAs , 2005, Nature Genetics.
[236] D. Pauleikhoff,et al. Prevalence of age‐related macular degeneration , 1995, Current opinion in ophthalmology.
[237] A. Hofman,et al. Genetic association of apolipoprotein E with age-related macular degeneration. , 1998, American journal of human genetics.
[238] D. Paikl,et al. Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age‐related macular degeneration , 2011, Acta ophthalmologica.
[239] Yue Han,et al. CETP/LPL/LIPC gene polymorphisms and susceptibility to age-related macular degeneration , 2015, Scientific Reports.
[240] M. Goumans,et al. Abnormal angiogenesis but intact hematopoietic potential in TGF‐β type I receptor‐deficient mice , 2001, The EMBO journal.
[241] M. Nardi,et al. Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration. , 2012, Pharmacogenomics.
[242] C. Hölscher,et al. Investigation of the human brain metabolome to identify potential markers for early diagnosis and therapeutic targets of Alzheimer's disease. , 2013, Analytical chemistry.
[243] Jennifer I. Lim,et al. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.
[244] Richard Wormald,et al. The estimated prevalence and incidence of late stage age related macular degeneration in the UK , 2012, British Journal of Ophthalmology.
[245] A. Salminen,et al. Genetic Variability in DNA Repair Proteins in Age-Related Macular Degeneration , 2012, International journal of molecular sciences.
[246] Usha Chakravarthy,et al. The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. , 2008, Ophthalmology.
[247] Joshua T. Mendell,et al. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1 , 2008, Proceedings of the National Academy of Sciences.
[248] A. Ashworth,et al. Genome-wide association study identifies a novel variant in RAD51B associated with male breast cancer risk , 2012, Nature Genetics.
[249] S. Fauser,et al. Genetic predictive biomarkers of anti-VEGF treatment response in patients with neovascular age-related macular degeneration. , 2015, Survey of ophthalmology.
[250] R. Klein,et al. Relationship of dietary fat to age-related maculopathy in the Third National Health and Nutrition Examination Survey. , 2001, Archives of ophthalmology.
[251] Richard Mayeux,et al. Biomarkers: Potential uses and limitations , 2004 .
[252] G. Ying,et al. VEGFR2 Gene Polymorphisms and Response to Anti-Vascular Endothelial Growth Factor Therapy in Age-Related Macular Degeneration. , 2015, Ophthalmology.
[253] Pardis C Sabeti,et al. Identification of Two Independent Risk Factors for Lupus within the MHC in United Kingdom Families , 2007, PLoS genetics.
[254] M. Kamei,et al. TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. , 1999, Investigative ophthalmology & visual science.
[255] Zhenglin Yang,et al. Associations of the C2-CFB-RDBP-SKIV2L locus with age-related macular degeneration and polypoidal choroidal vasculopathy. , 2013, Ophthalmology.
[256] L. Claesson‐Welsh,et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 , 2003, Nature Medicine.
[257] R. Braun,et al. DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration , 2011, Nature.
[258] B. Rosner,et al. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. , 2003, Archives of ophthalmology.
[259] P. Mitchell,et al. Elevated serum homocysteine, low serum vitamin B12, folate, and age-related macular degeneration: the Blue Mountains Eye Study. , 2007, American journal of ophthalmology.
[260] J. Kowalak,et al. Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. , 2007, Investigative ophthalmology & visual science.
[261] M. O'dorisio,et al. Somatostatin inhibits IGF-1 mediated induction of VEGF in human retinal pigment epithelial cells. , 2004, Experimental eye research.
[262] P. Mitchell,et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis , 2010, BMC ophthalmology.
[263] F S Rosenthal,et al. The long-term effects of visible light on the eye. , 1992, Archives of ophthalmology.
[264] T. Lai,et al. Ethnic differences in the association of SERPING1 with age-related macular degeneration and polypoidal choroidal vasculopathy , 2015, Scientific Reports.
[265] M. Cicardi,et al. C1-inhibitor deficiency and angioedema. , 2001, Molecular immunology.
[266] P. Campochiaro,et al. MicroRNAs regulate ocular neovascularization. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[267] Dean P. Jones,et al. Metabolome-Wide Association Study of Neovascular Age-Related Macular Degeneration , 2013, PloS one.
[268] J. Sahel,et al. R102G polymorphism of the C3 gene associated with exudative age-related macular degeneration in a French population , 2010, Molecular vision.
[269] R. T. Smith,et al. A Candidate Gene Association Study Identifies DAPL1 as a Female-Specific Susceptibility Locus for Age-Related Macular Degeneration (AMD) , 2015, NeuroMolecular Medicine.
[270] B. J. Klevering,et al. Mutations in the ABCA4 (ABCR) gene are the major cause of autosomal recessive cone-rod dystrophy. , 2000, American journal of human genetics.
[271] S. Libutti,et al. Functional characterization of filamin a interacting protein 1-like, a novel candidate for antivascular cancer therapy. , 2008, Cancer research.
[272] C. Kahn,et al. Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. , 2003, The Journal of clinical investigation.
[273] Kang Zhang,et al. Lack of association of CFD polymorphisms with advanced age-related macular degeneration , 2010, Molecular vision.
[274] Yara T. E. Lechanteur,et al. Nature Genetics Advance Online Publication , 2022 .
[275] T Michael Redmond,et al. Inflammatory cytokines regulate microRNA-155 expression in human retinal pigment epithelial cells by activating JAK/STAT pathway. , 2010, Biochemical and biophysical research communications.
[276] V. Sheffield,et al. Recommendations for genetic testing of inherited eye diseases: report of the American Academy of Ophthalmology task force on genetic testing. , 2012, Ophthalmology.
[277] A. Swaroop,et al. Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration. , 2005, Ophthalmology.
[278] R. Klein,et al. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. , 2006, Ophthalmology.
[279] Ling Zhao,et al. RAD51 gene is associated with advanced age-related macular degeneration in Chinese population. , 2013, Clinical biochemistry.
[280] P. Mitchell,et al. Family history and age-related maculopathy: the Blue Mountains Eye Study. , 1998, Australian and New Zealand journal of ophthalmology.
[281] L. Žorić,et al. The Association of Lipoprotein Parameters and C-Reactive Protein in Patients with Age-Related Macular Degeneration , 2011, Ophthalmic Research.
[282] Johannes R. Vingerling,et al. The prevalence of age-related maculopathy in the Rotterdam Study. , 1995, Ophthalmology.
[283] R. Guymer,et al. C-reactive protein levels and complement factor H polymorphism interaction in age-related macular degeneration and its progression. , 2010, Ophthalmology.
[284] M. Duffy,et al. Validation of new cancer biomarkers: a position statement from the European group on tumor markers. , 2015, Clinical chemistry.
[285] R. Shiekhattar,et al. MicroRNA biogenesis and cancer. , 2005, Cancer research.
[286] Ronald Klein,et al. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. , 2007, Ophthalmology.
[287] P. Campochiaro,et al. Localization of TIMP-3 mRNA expression to the retinal pigment epithelium. , 1996, Investigative ophthalmology & visual science.
[288] R. Lavker,et al. MicroRNAs of the mammalian eye display distinct and overlapping tissue specificity. , 2006, Molecular vision.
[289] Tunde Peto,et al. Prevalence of age-related macular degeneration in elderly Caucasians: the Tromsø Eye Study. , 2012, Ophthalmology.
[290] A. Munnich,et al. rs5888 Variant of SCARB1 Gene Is a Possible Susceptibility Factor for Age-Related Macular Degeneration , 2009, PloS one.
[291] A. D. den Hollander,et al. Complement factor D in age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.
[292] R. Hindges,et al. Non-Coding RNAs in Retinal Development , 2012, International journal of molecular sciences.
[293] Peter Carmeliet,et al. VEGF: a critical player in neurodegeneration. , 2004, The Journal of clinical investigation.
[294] R. Mayeux. Biomarkers: Potential uses and limitations , 2004, NeuroRX.
[295] A. Anand,et al. New biomarker for neovascular age-related macular degeneration: eotaxin-2. , 2012, DNA and cell biology.
[296] V. Sheffield,et al. Missense variations in the fibulin 5 gene and age-related macular degeneration. , 2004, The New England journal of medicine.
[297] M. Fukuda,et al. Functional Analysis of Slac2-c/MyRIP as a Linker Protein between Melanosomes and Myosin VIIa*[boxs] , 2005, Journal of Biological Chemistry.
[298] L. Langeberg,et al. MyRIP Anchors Protein Kinase A to the Exocyst Complex* , 2007, Journal of Biological Chemistry.
[299] Xianjun Zhu,et al. Associations of 6p21.3 Region with Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy , 2016, Scientific Reports.
[300] Min Zhao,et al. CFB/C2 Gene Polymorphisms and Risk of Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis , 2012, Current eye research.
[301] J. Haines,et al. C3 R102G polymorphism increases risk of age-related macular degeneration. , 2008, Human molecular genetics.
[302] Laura Harwood,et al. Prediction of microRNAs affecting mRNA expression during retinal development , 2010, BMC Developmental Biology.
[303] A. Negi,et al. Positive association of common variants in CD36 with neovascular age-related macular degeneration , 2009, Aging.
[304] I. Namer,et al. Serum analysis by 1H Nuclear Magnetic Resonance spectroscopy: a new tool for distinguishing neuromyelitis optica from multiple sclerosis , 2014, Multiple sclerosis.
[305] R. Kendall,et al. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[306] W. Lukiw,et al. Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD). , 2012, International journal of biochemistry and molecular biology.
[307] P. Bovolenta,et al. miR-204 is required for lens and retinal development via Meis2 targeting , 2010, Proceedings of the National Academy of Sciences.
[308] I. Rodriguez,et al. Intraretinal lipid transport is dependent on high density lipoprotein-like particles and class B scavenger receptors. , 2006, Molecular vision.
[309] K. Nakanishi,et al. A2E, a lipofuscin fluorophore, in human retinal pigmented epithelial cells in culture. , 1999, Investigative ophthalmology & visual science.
[310] F. Behar-Cohen,et al. Morphologic and electroretinographic phenotype of SR-BI knockout mice after a long-term atherogenic diet. , 2009, Investigative ophthalmology & visual science.
[311] Marianne Pons,et al. Nicotine increases the VEGF/PEDF ratio in retinal pigment epithelium: a possible mechanism for CNV in passive smokers with AMD. , 2011, Investigative ophthalmology & visual science.
[312] M. Klein,et al. Update on the role of genetics in the onset of age-related macular degeneration , 2011, Clinical ophthalmology.
[313] S. Fekete,et al. Association of apolipoprotein E polymorphism with age-related macular degeneration and Alzheimer's disease in south-western Hungary. , 2007, Ideggyogyaszati szemle.
[314] B. Munoz,et al. Racial differences and other risk factors for incidence and progression of age-related macular degeneration: Salisbury Eye Evaluation (SEE) Project. , 2008, Investigative ophthalmology & visual science.
[315] C. Delcourt,et al. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study , 2001, Ophthalmic epidemiology.
[316] J. Hu,et al. Polymorphisms in CFH, HTRA1 and CX3CR1 confer risk to exudative age-related macular degeneration in Han Chinese , 2010, British Journal of Ophthalmology.
[317] R. J. Ross,et al. Genetic markers and biomarkers for age-related macular degeneration , 2007, Expert review of ophthalmology.
[318] Jeremy Murray,et al. Inhibiting Alternative Pathway Complement Activation by Targeting the Factor D Exosite* , 2012, The Journal of Biological Chemistry.
[319] A. Lakkaraju,et al. Apolipoprotein E Isoforms and AMD. , 2016, Advances in experimental medicine and biology.
[320] M. Dean,et al. Retinitis pigmentosa caused by a homozygous mutation in the Stargardt disease gene ABCR , 1998, Nature Genetics.
[321] P. Handford,et al. Biophysical characterisation of fibulin-5 proteins associated with disease. , 2010, Journal of molecular biology.
[322] J. Escardo,et al. VEGF polymorphisms are associated with neovascular age-related macular degeneration. , 2006, Human molecular genetics.
[323] P. Mitchell,et al. Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. , 1996, Ophthalmology.
[324] M. Blumenkranz,et al. Risk factors in age-related maculopathy complicated by choroidal neovascularization. , 1986, Ophthalmology.
[325] R. Nagaraj,et al. Plasma Protein Pentosidine and Carboxymethyllysine, Biomarkers for Age-related Macular Degeneration* , 2009, Molecular & Cellular Proteomics.
[326] J. Provis,et al. Small interfering RNA-mediated suppression of Ccl2 in Müller cells attenuates microglial recruitment and photoreceptor death following retinal degeneration , 2012, Journal of Neuroinflammation.
[327] S. Banfi,et al. Identification and characterization of microRNAs expressed in the mouse eye. , 2007, Investigative ophthalmology & visual science.
[328] J. Bena,et al. Assessing Susceptibility to Age-related Macular Degeneration with Proteomic and Genomic Biomarkers* , 2009, Molecular & Cellular Proteomics.
[329] A Hofman,et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. , 2001, Ophthalmology.
[330] Shih-Jen Chen,et al. Different Plasma Levels of Vascular Endothelial Growth Factor and Nitric Oxide between Patients with Choroidal and Retinal Neovascularization , 2004, Ophthalmologica.
[331] U. Greferath,et al. Ccl2/Cx3cr1 knockout mice have inner retinal dysfunction but are not an accelerated model of AMD. , 2012, Investigative ophthalmology & visual science.
[332] P. Debré,et al. CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. , 2007, The Journal of clinical investigation.
[333] L. Marmorstein,et al. Focus on molecules: fibulin-3 (EFEMP1). , 2010, Experimental Eye Research.
[334] F. Alkuraya,et al. Mutation of IGFBP7 causes upregulation of BRAF/MEK/ERK pathway and familial retinal arterial macroaneurysms. , 2011, American journal of human genetics.
[335] I. Suñer,et al. Nicotine increases size and severity of experimental choroidal neovascularization. , 2004, Investigative ophthalmology & visual science.
[336] J. Qian,et al. MicroRNA profile of the developing mouse retina. , 2010, Investigative ophthalmology & visual science.
[337] W. Gordon,et al. Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. , 2011, Annual review of nutrition.
[338] S. Russell,et al. Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[339] N. Hamajima,et al. Elevated C-reactive protein levels and ARMS2/HTRA1 gene variants in subjects without age-related macular degeneration , 2010, Molecular vision.
[340] B. Fridley,et al. Complement component 3 (C3) haplotypes and risk of advanced age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.
[341] Yusuke Nakamura,et al. Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population , 2011, Nature Genetics.
[342] Ivana K. Kim,et al. CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration. , 2013, Ophthalmology.
[343] R. Klein,et al. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.
[344] Johanna M Seddon,et al. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. , 2003, Ophthalmology.
[345] S. Bernstein,et al. Interaction of Complement Factor H and Fibulin3 in Age-Related Macular Degeneration , 2013, PloS one.
[346] B. Rosner,et al. Peripheral retinal drusen and reticular pigment: association with CFHY402H and CFHrs1410996 genotypes in family and twin studies. , 2009, Investigative ophthalmology & visual science.
[347] R. Sperduto,et al. Systemic hypertension and age-related maculopathy in the Framingham Study. , 1986, Archives of ophthalmology.
[348] R. Hennekam,et al. Peters Plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase. , 2006, American journal of human genetics.
[349] I. Deary,et al. Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.
[350] A. Edwards,et al. Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.
[351] N. Camp,et al. A Variant of the HTRA1 Gene Increases Susceptibility to Age-Related Macular Degeneration , 2006, Science.
[352] G. Superti-Furga,et al. Complement factor H binds malondialdehyde epitopes and protects from oxidative stress , 2011, Nature.
[353] D. DeMets,et al. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.
[354] B. Rosner,et al. Smoking, dietary betaine, methionine, and vitamin D in monozygotic twins with discordant macular degeneration: epigenetic implications. , 2011, Ophthalmology.
[355] R. Klein,et al. The relationship between iris color, hair color, and skin sun sensitivity and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. , 2003, Ophthalmology.
[356] J. Bena,et al. Proteomic and genomic biomarkers for age-related macular degeneration. , 2010, Advances in experimental medicine and biology.
[357] Yvonne Vergouwe,et al. Prognosis and prognostic research: what, why, and how? , 2009, BMJ : British Medical Journal.
[358] J. Martin Collinson,et al. Corneal avascularity is due to soluble VEGF receptor-1 , 2006, Nature.
[359] R. Klein,et al. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. , 2002, Ophthalmology.
[360] R. Shivdasani. MicroRNAs: regulators of gene expression and cell differentiation. , 2006, Blood.
[361] A. Negi,et al. Role of RDBP and SKIV2L variants in the major histocompatibility complex class III region in polypoidal choroidal vasculopathy etiology. , 2009, Ophthalmology.
[362] P.T.V.M. de Jong,et al. Mechanisms of disease: Age-related macular degeneration , 2006 .
[363] Laura Mariani,et al. MicroRNAs modulate the angiogenic properties of HUVECs. , 2006, Blood.
[364] L. Almasy,et al. Genetic and environmental factors influencing the human factor H plasma levels , 2004, Immunogenetics.
[365] D. English,et al. Apolipoprotein E gene associations in age-related macular degeneration: the Melbourne Collaborative Cohort Study. , 2012, American journal of epidemiology.
[366] O. Larsson,et al. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor. , 2008, Investigative ophthalmology & visual science.
[367] K. Gengyo-Ando,et al. Identification of a novel ADAMTS9/GON-1 function for protein transport from the ER to the Golgi , 2012, Molecular biology of the cell.
[368] J. Lupski,et al. The rod photoreceptor ATP-binding cassette transporter gene, ABCR, and retinal disease: from monogenic to multifactorial , 1999, Vision Research.
[369] R. Klein,et al. Effect of the Y402H variant in the complement factor H gene on the incidence and progression of age-related macular degeneration: results from multistate models applied to the Beaver Dam Eye Study. , 2012, Archives of ophthalmology.
[370] H. Aounallah-Skhiri,et al. Y402H Polymorphism in Complement Factor H and Age-Related Macular Degeneration in the Tunisian Population , 2013, Ophthalmic Research.
[371] D F Schorderet,et al. Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. , 2001, Archives of ophthalmology.
[372] R. Guymer,et al. Variants in the APOE gene are associated with improved outcome after anti-VEGF treatment for neovascular AMD. , 2011, Investigative ophthalmology & visual science.
[373] C. Keilhauer,et al. A subgroup of age-related macular degeneration is associated with mono-allelic sequence variants in the ABCA4 gene. , 2012, Investigative ophthalmology & visual science.
[374] Qinbo Zhou,et al. miRNAs as potential therapeutic targets for age-related macular degeneration. , 2012, Future medicinal chemistry.
[375] Lois E. H. Smith,et al. Netrin-1 – DCC Signaling Systems and Age-Related Macular Degeneration , 2015, PloS one.
[376] M. Dziejman,et al. IFN-γ-Inducible Protein 10 (IP-10; CXCL10)-Deficient Mice Reveal a Role for IP-10 in Effector T Cell Generation and Trafficking1 , 2002, The Journal of Immunology.
[377] Takako Sasaki,et al. Formation and progression of sub-retinal pigment epithelium deposits in Efemp1 mutation knock-in mice: a model for the early pathogenic course of macular degeneration. , 2007, Human molecular genetics.
[378] A E Fletcher,et al. 28 000 Cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking , 2005, British Journal of Ophthalmology.
[379] I. Bhutto,et al. C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration , 2011, British Journal of Ophthalmology.
[380] Ru-Fang Yeh,et al. miR-126 regulates angiogenic signaling and vascular integrity. , 2008, Developmental cell.
[381] J. Saaddine,et al. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. , 2009, Archives of ophthalmology.
[382] V. Ambros,et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.
[383] Dean Y. Li,et al. Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1 , 2013, eLife.
[384] C. Lillo,et al. Microtubule motors transport phagosomes in the RPE, and lack of KLC1 leads to AMD-like pathogenesis , 2015, The Journal of cell biology.
[385] B. Ghebrehiwet,et al. Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement. , 1985, The Journal of clinical investigation.
[386] R. Shankar,et al. The regulatory epicenter of miRNAs , 2011, Journal of Biosciences.
[387] R Garside,et al. The harmful health effects of recreational ecstasy: a systematic review of observational evidence. , 2009, Health technology assessment.
[388] B. Rosner,et al. Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration , 2010, Molecular vision.
[389] Lars G Fritsche,et al. Evidence of association of APOE with age‐related macular degeneration ‐ a pooled analysis of 15 studies , 2011, Human mutation.
[390] W. Berger,et al. Genetic association with response to intravitreal ranibizumab in patients with neovascular AMD. , 2011, Investigative ophthalmology & visual science.
[391] M. Petersen,et al. Age-related macular degeneration: genetic and clinical findings , 2011, Clinical chemistry and laboratory medicine.
[392] Paul S. Bernstein,et al. Mutation of the Stargardt Disease Gene (ABCR) in Age-Related Macular Degeneration , 1997 .
[393] A. D. den Hollander,et al. Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration. , 2015, Ophthalmology.
[394] E. Stone,et al. Fibulin-5 distribution in human eyes: relevance to age-related macular degeneration. , 2007, Experimental eye research.
[395] Daniel Ardeljan,et al. Aging is not a disease: Distinguishing age-related macular degeneration from aging , 2013, Progress in Retinal and Eye Research.
[396] A. Harris,et al. Ocular perfusion and age-related macular degeneration. , 2001, Acta ophthalmologica Scandinavica.
[397] Young H. Kwon,et al. Genome-wide analysis of copy number variants in age-related macular degeneration , 2010, Human Genetics.
[398] Arnald Alonso,et al. Analytical Methods in Untargeted Metabolomics: State of the Art in 2015 , 2015, Front. Bioeng. Biotechnol..
[399] R. Milton,et al. Evaluation of plasma homocysteine and risk of age-related macular degeneration. , 2006, American journal of ophthalmology.
[400] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[401] K. Damji,et al. Familial occurrence of artefactual ocular hypertension from thick corneas and of primary open angle glaucoma in a French Canadian kindred , 2000, Ophthalmic genetics.
[402] Ai-yi Zhou,et al. Association between complementary factor H Y402H polymorphisms and age-related macular degeneration in Chinese: Systematic review and meta-analysis. , 2012, International journal of ophthalmology.
[403] Yu Qian-Qian,et al. Nonsynonymous single nucleotide polymorphisms in the complement component 3 gene are associated with risk of age-related macular degeneration: a meta-analysis. , 2015, Gene.
[404] S. Rodríguez de Córdoba,et al. Relevance of complement factor H-related 1 (CFHR1) genotypes in age-related macular degeneration. , 2012, Investigative ophthalmology & visual science.
[405] Xiaodong Sun,et al. Homocysteine and the risk of age-related macular degeneration: a systematic review and meta-analysis , 2015, Scientific Reports.
[406] The physiological impact of microRNA gene regulation in the retina , 2012, Cellular and Molecular Life Sciences.
[407] Jason H. Moore,et al. Chapter 11: Genome-Wide Association Studies , 2012, PLoS Comput. Biol..
[408] Y. Conley,et al. Associations between genetic polymorphisms of insulin-like growth factor axis genes and risk for age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.
[409] C. Keilhauer,et al. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). , 2010, Human molecular genetics.
[410] J. Szemraj,et al. Serum MicroRNAs as Potential Biomarkers of AMD , 2015, Medical science monitor : international medical journal of experimental and clinical research.
[411] F. Ferris,et al. Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration , 2014, BMC Ophthalmology.
[412] R. Klein,et al. Sunlight exposure, pigmentation, and incident age-related macular degeneration. , 2014, Investigative ophthalmology & visual science.
[413] Alston Callahan,et al. The role of inflammation in the pathogenesis of age-related macular degeneration. , 2006, Survey of ophthalmology.
[414] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[415] Maria P. Pavlou,et al. The long journey of cancer biomarkers from the bench to the clinic. , 2013, Clinical chemistry.
[416] R. Klein,et al. Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study. , 1998, American journal of epidemiology.
[417] N. Cook,et al. Prospective Study of Plasma Homocysteine Level and Risk of Age-Related Macular Degeneration in Women , 2015, Ophthalmic epidemiology.
[418] S. Rodríguez de Córdoba,et al. The human complement factor H: functional roles, genetic variations and disease associations. , 2004, Molecular immunology.
[419] F P Perera,et al. Molecular epidemiology: recent advances and future directions. , 2000, Carcinogenesis.
[420] Usha Chakravarthy,et al. Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. , 2012, Ophthalmology.
[421] A. Kay,et al. Eotaxin (CCL11) and Eotaxin-2 (CCL24) Induce Recruitment of Eosinophils, Basophils, Neutrophils, and Macrophages As Well As Features of Early- and Late-Phase Allergic Reactions Following Cutaneous Injection in Human Atopic and Nonatopic Volunteers1 , 2002, The Journal of Immunology.
[422] Y. Benjamini,et al. Association of neovascular age-related macular degeneration and hyperhomocysteinemia. , 2004, American journal of ophthalmology.
[423] V. Monnier,et al. Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia. , 1991, Diabetes/metabolism reviews.
[424] Gabriëlle H S Buitendijk,et al. Insights into the Genetic Architecture of Early Stage Age-Related Macular Degeneration: A Genome-Wide Association Study Meta-Analysis , 2013, PloS one.
[425] Y. Arsenijévic,et al. Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[426] J. Neitz,et al. Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. , 2001, American journal of ophthalmology.
[427] J. Gilbert,et al. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.
[428] S. Hawken,et al. Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study. , 2015, Ophthalmology.
[429] K. Blennow,et al. Association of complement factor H Y402H gene polymorphism with Alzheimer's disease , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[430] Sharon D. Solomon,et al. Racial differences in the prevalence of age-related macular degeneration: the Salisbury Eye Evaluation (SEE) Project. , 2008, Archives of ophthalmology.